| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/12/2007 | CN101035766A 3-(2-hydroxyphenyl) pyrazoles and their use as HSP90 modulators |
| 09/12/2007 | CN101033225A Process of preparing troipisetron |
| 09/12/2007 | CN101033224A Novel pyrimidines small molecular compound, its preparation method and use |
| 09/11/2007 | US7268230 Quinazoline compounds |
| 09/11/2007 | US7268159 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/07/2007 | WO2007101213A2 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100852A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | WO2007100739A1 Ccr5 antagonists useful for treating hiv |
| 09/07/2007 | WO2007100646A1 Multi-cyclic compounds and method of use |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | WO2007099385A1 Dipeptidyl peptidase iv inhibitor compounds and compositions |
| 09/07/2007 | WO2007098953A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/07/2007 | WO2007098835A1 Amino pyrymidine derivatives |
| 09/07/2007 | WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/07/2007 | WO2007058989A3 Quinazolines useful as modulators of voltage gated ion channels |
| 09/07/2007 | WO2007029156A3 Isoindoledione derivatives as adrenergic receptor antagonists |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2644069A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | CA2643323A1 Ccr5 antagonists useful for treating hiv |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | CA2641144A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/07/2007 | CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/07/2007 | CA2633069A1 New 3'-, 7-substituted indirubins and their applications |
| 09/06/2007 | US20070208174 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolone carboxylic acid ethyl ester is reacted with fluoroboric acid in the presence of poly(methylhydrosiloxane) |
| 09/06/2007 | US20070208164 Methods of synthesizing radiolabeled 3-cyano[14C]quinolines |
| 09/06/2007 | US20070208070 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/06/2007 | US20070208064 Ion channel modulators |
| 09/06/2007 | US20070208063 Imidazole-based compounds, compositions comprising them and methods of their use |
| 09/06/2007 | US20070208059 Therapeutic Agents |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208044 Compounds and therapeutical use thereof |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208034 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208031 Substituted Diketopiperazines as Oxytocin Antagonists |
| 09/06/2007 | US20070208030 Tetrahydroindolone Derivatives for Treament of Neurological Conditions |
| 09/06/2007 | US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| 09/06/2007 | US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases |
| 09/06/2007 | US20070208022 Hiv inhibiting 5-carbo- or heterocyclyl substituted pyrimidines |
| 09/06/2007 | US20070208020 P70S6 Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208018 Quinazoline Derivatives |
| 09/06/2007 | US20070208017 e.g. 3-(3-{[7-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}-amino)heptyl]oxy}propyl)benzenesulfonamide triphenylacetate; beta 2-adrenoreceptors stimulant, bronchodilator; reversible airways obstruction: asthma, chronic obstructive pulmonary disease (COPD), respiratory tract infection |
| 09/06/2007 | US20070208014 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 09/06/2007 | US20070208012 Modulation of Pathogenicity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208005 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 09/06/2007 | US20070208004 Indol-1-yl-acetic acid derivatives |
| 09/06/2007 | US20070207999 New Compounds |
| 09/06/2007 | US20070207994 3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto |
| 09/06/2007 | US20070207992 Geldanamycin derivatives and method of use thereof |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207985 treating diabetes, hyperglycemia, obesity, dyslipidemia, and hypertension; compounds are based on 1,2,4-triazine and fused ring derivatives thereof, for example 3-Adamantan-1-yl-5,6-dimethyl-1,2,4-triazine |
| 09/05/2007 | EP1829875A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/05/2007 | EP1829872A1 Processes for production of indole compounds |
| 09/05/2007 | EP1829871A1 Organic compound, charge-transporting material, and organic electroluminescent element |
| 09/05/2007 | EP1829861A2 Pyrrolidine ester derivatives active as oxytocin antagonists |
| 09/05/2007 | EP1828183A1 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 09/05/2007 | EP1828170A2 Process for preparing voriconazole |
| 09/05/2007 | EP1828169A2 Urea inhibitors of map kinases |
| 09/05/2007 | EP1828165A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/05/2007 | EP1828147A1 Quinoxalines as b-raf inhibitors |
| 09/05/2007 | EP1828146A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 09/05/2007 | EP1828144A2 Integrin antagonists useful as anticancer agents |
| 09/05/2007 | EP1828143A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 09/05/2007 | EP1828141A1 A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
| 09/05/2007 | EP1828124A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1828116A1 Pyrrolidine compounds |
| 09/05/2007 | EP1827439A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1618094B1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 09/05/2007 | EP1569638B1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | EP1197492B1 Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient |
| 09/05/2007 | EP1153016B1 Phenylsulfonyl ureas, methods for producing them and their use as herbicides and plant growth regulators |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN101031562A Imidazole-5-carboxylic acid derivative, its production and use |
| 09/05/2007 | CN101031560A Cyclic diaryl ureas suitable as tyrosine kinase inhibitors |
| 09/05/2007 | CN101031550A HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN100335478C Chemokine receptor binding heterocyclic compounds |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265149 Pyrazolylakoxy-substituted indoleacetic acid derivatives, e.g., {6-[2-methyl-5-(4-trifluoromethyl-phenyl)-2H-pyrazol-3-ylmethoxy]-indol-1-yl}-acetic acid; used for treatment and/or prevention of diseases modulated by PPAR delta and/or PPAR alpha agonists. |
| 09/04/2007 | US7265148 Substituted pyrrole-indoles |
| 09/04/2007 | US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C |
| 09/04/2007 | US7265144 Mixture with other active materials; controlling glucose metabolism |
| 09/04/2007 | US7265138 inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 09/04/2007 | US7265135 Antihistamines; cognition activators; Alzheimer's disease; antiepileptic agents; eating disorders; motion sickness; psychological disorders |